CD8A and neoplasm: Similar to NK cells, there were no significant differences in CD8+ T cell number (Fig. 5a) or phenotype (Fig. 5b-d) in the primary tumor with treatment, other than an increase in the frequency of Ki67+ CD8+ T cells (Fig. 5d), indicating an increased proliferative potential.